Table 4. The association between gender, age comorbidity and development of nasopharyngeal cancer.
Development of nasopharyngeal cancer | ||||
Variables | Category | High | Low | p-value |
Gender | Male | 47 (56.4%) | 37 (43.6%) | 0.003 |
Female | 36 (43.2%) | 48 (56.8%) | ||
Age | 0-10 years | 36 (43.4%) | 48 (56.6%) | 0.623 |
11-20 years | 36 (42.7%) | 48 (57.3%) | ||
21-30 years | 37 (43.6%) | 47 (56.4%) | ||
31-40 years | 37 (43.5%) | 47 (56.5%) | ||
41-50 years | 35 (42.1%) | 49 (57.9%) | ||
51-60 years | 36 (42.5%) | 48 (57.5%) | ||
61-70 years | 36 (42.7%) | 48 (57.3%) | ||
71 years old and more | 35 (41.8%) | 49(58.2%) | ||
Comorbidity | Asthma | 35 (41.4%) | 49 (58.6%) | 0.871 |
X Smoker | 37 (43.6%) | 47 (56.4%) | ||
Hyperlipidemia, ischemic heart disease | 37 (43.5%) | 47 (56.5%) | ||
Obesity | 35 (42.1%) | 49 (57.9%) | ||
Hypothyroidism | 37 (44.0%) | 47 (56.0%) | ||
Smoking | 36 (42.7%) | 48 (57.3%) | ||
Pre-diabetes | 38 (44.9%) | 46 (55.1%) | ||
None | 47 (56.2%) | 37 (43.8%) |